FenoMark develops and commercializes tools that enables next generation molecular testing.
FenoMark Diagnostics AB has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
FenoMark Diagnostics AB is headquartered in Stockholm, Sweden.
FenoMark develops and commercializes tools that enables next generation molecular testing.
FenoMark Diagnostics AB is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FenoMark Diagnostics AB — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/fenomark-diagnostics-ab. Accessed November 13, 2026.
VCBacked. (2025). FenoMark Diagnostics AB — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/fenomark-diagnostics-ab
{{cite web |title=FenoMark Diagnostics AB — Funding & Investors |url=https://www.vcbacked.co/company/fenomark-diagnostics-ab |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at FenoMark Diagnostics AB? Request a listing update